News & Events
Here are the project's latest news related to scientific events, publications, clinical trials and workpakages' activities.
WP4
1septembre ... 1décembre
1septembre ... 1décembre
Join us - Research assistant in Immunology
The i3 laboratory (www.i3-immuno.fr) is seeking to recruit a research assistant with a strong interest in the analysis and interpretation of lentiviral production and engineering for cell therapy.
WP2
Membranous nephropathy induced by enzyme replacement therapy (ERT)
A new cause of membranous nephropathy, a renal disease induced by formation of immune deposits in the renal glomerulus, has been identified in a child with Pompe disease treated with recombinant arylsulfatase. ERT could be resumed after tolerance inductio...
DHU:i2B
Launch Horizon 2020
With recognized expertise from bench to bedside in the field of inflammatory and autoimmune disorders, the i2B consortium is open to collaborations within the newly launched 2014-2015 workprogram of H2020, specially for the "Personal...
WP3
Lancement de l'essai MS-IL2
MS-IL2 vient d'obtenir l'autorisation de l'ANSM pour étudier le potentiel thérapeutique d'IL2 à faibles doses dans la sclérose en plaques.
WP1
Specialized consultations
Specialized consultations have been established within i2B in order to accelerate patient access to various specialists in the consortium. This comprises internal medicine, pediatrics, and subspecialty departments. For furt...
WP3
TRANSREG has been launched.
TRANSREG is a multicenter, uncontrolled, open-label study, comparing biological and clinical responses to the administration of low dose IL2 across 11 selected autoimmune diseases (12 patients/disease) including heumatoid arthritis,...